Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis
Leflunomide can be used in management of psoriatic disease. Leflunomide's active metabolite, teriflunomide, is used in the treatment of multiple sclerosis and has unexpectedly been rarely reported to induce pustular psoriasis. In this report, we present a patient with multiple sclerosis who dev...
Gespeichert in:
| Veröffentlicht in: | Dermatology online journal 2024-08, Vol.30 (4) |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | |
| container_title | Dermatology online journal |
| container_volume | 30 |
| creator | Mueller, Kyle Pei, Susan Kuraitis, Drew |
| description | Leflunomide can be used in management of psoriatic disease. Leflunomide's active metabolite, teriflunomide, is used in the treatment of multiple sclerosis and has unexpectedly been rarely reported to induce pustular psoriasis. In this report, we present a patient with multiple sclerosis who developed inverse psoriasis after starting teriflunomide. |
| doi_str_mv | 10.5070/D330464111 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3146570197</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3146570197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1271-1c7a6ba3dd0d70211ab0af4193f49347a463ab57aadbcc3414aab17bd7350ea43</originalsourceid><addsrcrecordid>eNpNkE1Lw0AQhhdRbK1e_AGSowjRnewma47S-gUFL_UcJtmJrGyycTep-u9NadVe5ouHl-Fh7Bz4dcoVv1kIwWUmAeCATYHfqjgZ6-HePGEnIbxznnCZimM2EXkmpVQwZbQib2o7tK4xmmJPFnvSkaY1Wdc11PaRqyPTrskHirrgvMFgQoStjj7deGtN-7ZBOk8xfZnQb_bO4sewh5-yoxptoLNdn7HXh_vV_Clevjw-z--WcQWJghgqhVmJQmuuFU8AsORYS8hFLXMhFcpMYJkqRF1WlZAgEUtQpVYi5YRSzNjlNrfzbnwg9EVjQkXWYktuCIUAmaWKQ65G9GqLVt6F4KkuOm8a9N8F8GKjtfjXOsIXu9yhbEj_ob8exQ8kz3P3</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3146570197</pqid></control><display><type>article</type><title>Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mueller, Kyle ; Pei, Susan ; Kuraitis, Drew</creator><creatorcontrib>Mueller, Kyle ; Pei, Susan ; Kuraitis, Drew</creatorcontrib><description>Leflunomide can be used in management of psoriatic disease. Leflunomide's active metabolite, teriflunomide, is used in the treatment of multiple sclerosis and has unexpectedly been rarely reported to induce pustular psoriasis. In this report, we present a patient with multiple sclerosis who developed inverse psoriasis after starting teriflunomide.</description><identifier>ISSN: 1087-2108</identifier><identifier>EISSN: 1087-2108</identifier><identifier>DOI: 10.5070/D330464111</identifier><identifier>PMID: 39644471</identifier><language>eng</language><publisher>United States</publisher><subject>Crotonates - adverse effects ; Crotonates - therapeutic use ; Humans ; Hydroxybutyrates ; Multiple Sclerosis - drug therapy ; Multiple Sclerosis, Relapsing-Remitting - complications ; Multiple Sclerosis, Relapsing-Remitting - drug therapy ; Nitriles - adverse effects ; Nitriles - therapeutic use ; Psoriasis - chemically induced ; Psoriasis - drug therapy ; Toluidines - adverse effects ; Toluidines - therapeutic use</subject><ispartof>Dermatology online journal, 2024-08, Vol.30 (4)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39644471$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mueller, Kyle</creatorcontrib><creatorcontrib>Pei, Susan</creatorcontrib><creatorcontrib>Kuraitis, Drew</creatorcontrib><title>Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis</title><title>Dermatology online journal</title><addtitle>Dermatol Online J</addtitle><description>Leflunomide can be used in management of psoriatic disease. Leflunomide's active metabolite, teriflunomide, is used in the treatment of multiple sclerosis and has unexpectedly been rarely reported to induce pustular psoriasis. In this report, we present a patient with multiple sclerosis who developed inverse psoriasis after starting teriflunomide.</description><subject>Crotonates - adverse effects</subject><subject>Crotonates - therapeutic use</subject><subject>Humans</subject><subject>Hydroxybutyrates</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Multiple Sclerosis, Relapsing-Remitting - complications</subject><subject>Multiple Sclerosis, Relapsing-Remitting - drug therapy</subject><subject>Nitriles - adverse effects</subject><subject>Nitriles - therapeutic use</subject><subject>Psoriasis - chemically induced</subject><subject>Psoriasis - drug therapy</subject><subject>Toluidines - adverse effects</subject><subject>Toluidines - therapeutic use</subject><issn>1087-2108</issn><issn>1087-2108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE1Lw0AQhhdRbK1e_AGSowjRnewma47S-gUFL_UcJtmJrGyycTep-u9NadVe5ouHl-Fh7Bz4dcoVv1kIwWUmAeCATYHfqjgZ6-HePGEnIbxznnCZimM2EXkmpVQwZbQib2o7tK4xmmJPFnvSkaY1Wdc11PaRqyPTrskHirrgvMFgQoStjj7deGtN-7ZBOk8xfZnQb_bO4sewh5-yoxptoLNdn7HXh_vV_Clevjw-z--WcQWJghgqhVmJQmuuFU8AsORYS8hFLXMhFcpMYJkqRF1WlZAgEUtQpVYi5YRSzNjlNrfzbnwg9EVjQkXWYktuCIUAmaWKQ65G9GqLVt6F4KkuOm8a9N8F8GKjtfjXOsIXu9yhbEj_ob8exQ8kz3P3</recordid><startdate>20240815</startdate><enddate>20240815</enddate><creator>Mueller, Kyle</creator><creator>Pei, Susan</creator><creator>Kuraitis, Drew</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240815</creationdate><title>Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis</title><author>Mueller, Kyle ; Pei, Susan ; Kuraitis, Drew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1271-1c7a6ba3dd0d70211ab0af4193f49347a463ab57aadbcc3414aab17bd7350ea43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Crotonates - adverse effects</topic><topic>Crotonates - therapeutic use</topic><topic>Humans</topic><topic>Hydroxybutyrates</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Multiple Sclerosis, Relapsing-Remitting - complications</topic><topic>Multiple Sclerosis, Relapsing-Remitting - drug therapy</topic><topic>Nitriles - adverse effects</topic><topic>Nitriles - therapeutic use</topic><topic>Psoriasis - chemically induced</topic><topic>Psoriasis - drug therapy</topic><topic>Toluidines - adverse effects</topic><topic>Toluidines - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mueller, Kyle</creatorcontrib><creatorcontrib>Pei, Susan</creatorcontrib><creatorcontrib>Kuraitis, Drew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatology online journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mueller, Kyle</au><au>Pei, Susan</au><au>Kuraitis, Drew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis</atitle><jtitle>Dermatology online journal</jtitle><addtitle>Dermatol Online J</addtitle><date>2024-08-15</date><risdate>2024</risdate><volume>30</volume><issue>4</issue><issn>1087-2108</issn><eissn>1087-2108</eissn><abstract>Leflunomide can be used in management of psoriatic disease. Leflunomide's active metabolite, teriflunomide, is used in the treatment of multiple sclerosis and has unexpectedly been rarely reported to induce pustular psoriasis. In this report, we present a patient with multiple sclerosis who developed inverse psoriasis after starting teriflunomide.</abstract><cop>United States</cop><pmid>39644471</pmid><doi>10.5070/D330464111</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1087-2108 |
| ispartof | Dermatology online journal, 2024-08, Vol.30 (4) |
| issn | 1087-2108 1087-2108 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3146570197 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Crotonates - adverse effects Crotonates - therapeutic use Humans Hydroxybutyrates Multiple Sclerosis - drug therapy Multiple Sclerosis, Relapsing-Remitting - complications Multiple Sclerosis, Relapsing-Remitting - drug therapy Nitriles - adverse effects Nitriles - therapeutic use Psoriasis - chemically induced Psoriasis - drug therapy Toluidines - adverse effects Toluidines - therapeutic use |
| title | Teriflunomide-related development of inverse psoriasis and worsening of pre-existing plaque psoriasis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A43%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Teriflunomide-related%20development%20of%20inverse%20psoriasis%20and%20worsening%20of%20pre-existing%20plaque%20psoriasis&rft.jtitle=Dermatology%20online%20journal&rft.au=Mueller,%20Kyle&rft.date=2024-08-15&rft.volume=30&rft.issue=4&rft.issn=1087-2108&rft.eissn=1087-2108&rft_id=info:doi/10.5070/D330464111&rft_dat=%3Cproquest_cross%3E3146570197%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3146570197&rft_id=info:pmid/39644471&rfr_iscdi=true |